Insights

IMAX Corporation Reiterated With A Buy At Canaccord

In a research note issued earlier today, Canaccord analyst Aravinda Galappatthige maintained coverage with a “Buy” rating on IMAX Corporation (IMAX), and a price target of $34.50 a …

Canaccord Maintains Buy Rating On TW Telecom

In a research note issued earlier today, Canaccord analyst Gregory Miller maintained coverage with a “Buy” rating on TW Telecom Inc. (TWTC) and a price target of …

UBS Raises Esterline Technologies Price Target To $130

UBS analyst David E. Strauss reiterates a ‘Buy’ rating on Esterline Technologies Corp.

Maxim Reiterates Buy Rating And Raises Achillion Price Target To $22

In a research note issued today, Maxim Group analyst Jason Kolbert reiterated a Buy rating and boosted his price target on Achillion Pharmaceuticals (ACHN) to …

H.C. Wainwright Reiterates Buy On United Therapeutics

In a research note issued this morning, H.C.

Vertex Shares Will Outperform The Biotech Sector, Says H.C. Wainwright

In a research note released this morning, H.C.

Roth Capital Maintains Buy Rating On Uranium Resources

Roth Capital reiterated coverage yesterday on Uranium Resources Inc. (URRE) with a Buy rating and $4.

UPDATE: Roth Capital Resumes Coverage On Conatus Pharmaceuticals

In a report published today, Roth Capital analyst Ed Arce resumed coverage on Conatus Pharmaceuticals Inc. (CNAT) with a Buy rating and $19.

We See An Attractive Risk/Reward In MPAA Shares, Says Roth Capital Analyst

In a research note issued this morning, Roth Capital maintained coverage with a “Buy” rating on Motorcar Parts of America, Inc. (MPAA) and a price target of $30.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts